KM-043

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameKM-043
Drug Alias NameN/A
ClassificationSmall molecules > Carbohydrate
Mechanisms of ActionDNA-directed DNA polymerase inhibitorsReverse transcriptase inhibitors
TargetsReverse transcriptaseDNA-directed DNA polymerase
Therapy Area/IndicationsNeoplasmsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesToyo Suisan Kaisha Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesToyo Suisan Kaisha Ltd +[2] 
Active IndicationsN/A
Inactive IndicationsNeoplasmsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A